Exaeris, Inyx USA unsecured creditors committee appointed

By Caroline Salls

Pittsburgh, July 13 - Exaeris, Inc. and Inyx USA, Ltd.'s U.S. Trustee appointed the official committee of unsecured creditors for the Inyx, Inc. U.S. subsidiaries' Chapter 11 case, according to a Friday filing with the U.S. Bankruptcy Court for the District of Delaware.

The committee is comprised of Pamela Paschal of Accentia Pharmaceuticals, Tampa, Fla.; Michael P. Ryan of Ventiv Commercial Services, LLC, Somerset, N.J.; and Niraj Ganatra of the International Union of United Auto Workers, Detroit.

Inyx is a pharmaceutical company based in New York that develops drug delivery technologies and products for the treatment of respiratory, allergy, dermatological, topical and cardiovascular conditions. The U.S. subsidiaries were placed in bankruptcy on July 2, and their Chapter 11 case number is 07-10887.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.